Ignite Creation Date:
2025-12-24 @ 4:57 PM
Ignite Modification Date:
2026-01-05 @ 12:59 PM
Study NCT ID:
NCT00872950
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2022-04-11
First Post:
2009-03-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)
Sponsor:
Lahey Clinic
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2001-040
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None